Skip to main content
. 2021 Mar 26;16(3):e0248761. doi: 10.1371/journal.pone.0248761

Table 4. Persistence patterns of different class of anti-migraine drugs.

Continuers Switchers Discontinuers P-value
N (%) N (%) N (%)
NSAIDs 36 (8.6) 62 (14.9) 317 (76.3) 0.001
Combination analgesics 41 (10.7) 70 (18.4) 269 (70.7) <0.001
Triptans 156 (57.5) 38 (14.0) 77 (28.4) 0.025
Triptans + NSAIDs 187 (54.5) 50 (14.5) 106 (30.9) 0.038
Prophylaxis drugs 32 (17.0) 16 (8.5) 140 (74.4) 0.002
Total 452 (28.5) 236 (14.8) 909 (57.3) <0.001

* Total (1597 N) Patients